Orion Biotechnology Receives Funding to Test OB-002 for Treatment of COVID-19
Ottawa, Canada, July 30, 2020 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering small protein therapeutics, today announced